Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Individualized blood management for non-cardiac surgeries

Official title: Individualized Acute Normovolemic Hemodilution for Non-cardiac Surgery With Anticipated High-dose Red Cells Transfusion

Run by West China Hospital · NCT06399536 · Data updated 2026-11-12

This study tests whether a personalized blood management technique can help adults having non-cardiac surgeries avoid needing blood transfusions.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorWest China Hospital
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedJune 1, 2024
Main results expectedMay 31, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 4, 2024
Trial IDNCT06399536 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 75 undergoing elective non-cardiac surgery with an anticipated need for more than 8 units of red blood cells.

Probably not a fit

Patients who refuse blood transfusions or have significant comorbidities such as cardiopulmonary insufficiency or renal impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the effects of individualized acute normovolemic hemodilution (ANH) on the need for red blood cell transfusions in adults undergoing non-cardiac surgeries with expected significant blood loss. The study aims to reduce the complications associated with allogeneic blood transfusions by employing a technique that dilutes blood volume while maintaining normal blood pressure. Participants will be randomly assigned to receive individualized ANH or standard care to evaluate the effectiveness of this approach in minimizing transfusion requirements.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the need for blood transfusions and associated complications during major surgeries.

How similar studies have gone: While ANH has shown mixed results in previous literature, this individualized approach may provide new insights and improvements in its application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing elective non-cardiac surgery with an anticipated red blood cells transfusion \>8 units (or 1600ml)
* Aged 18\~75 years
* Preoperative Hb level \> 120g/L for men and \> 110g/L for women.

Exclusion Criteria:

* Refusal of blood transfusion
* Cardiopulmonary insufficiency
* Cerebrovascular disease
* Renal impairment
* Hemoglobinopathies or blood system diseases
* Other situations not suitable for inclusion in clinical trial.

Where it's running

  • West China Hospital of Sichuan University
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.